Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 35.0555
Recommendation STRONG BUY
P/E 2.87
ROE 23.54 %
Capitalization 493,817,910 $
Dividend Yield 0.00 %
P/S 2.49
AII Position 66
P/E Position 8
ROE Position 125
Capitalization Position 708
Dividend Yield Position 594
Sales 198,110,000 $
10-Year Average Earnings 171,765,600 $
Shares Outstanding 145,669,000
Equity 729,779,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2018 12 198,110,000.00 $
2017 12 320,060,000.00 $
2016 12 244,301,000.00 $
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -68,859,000.00 $
2017 12 110,748,000.00 $
2016 12 63,606,000.00 $
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 729,779,000.00 $
2017 12 845,890,000.00 $
2016 12 755,423,000.00 $
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 145,669,000
2017 12 156,257,000
2016 12 164,192,000
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:



Google News for PDL BIOPHARMA:

US Post News - 1 hour ago
This Is (Another) Opportunity To Buy PDL BioPharma (PDLI ...
The recent performance of PDL BioPharma (NASDAQ:PDLI) stock in the market spoke loud and clear to investors as PDLI saw more than ...
FinBulletin - 15 hours ago
An uncommon forecasts for PDL BioPharma, Inc. (PDLI)
When looking at price performance, PDL BioPharma, Inc. (NASDAQ:PDLI) has experienced quite a remarkable year. This stock inclined to its ...
Nyse NewsToday (press release)
Practical Stock Evaluation: PDL BioPharma, Inc. (PDLI)
Practical Stock Evaluation: PDL BioPharma, Inc. (PDLI) ... To review the PDLI previous performance, look at its past history, which highlighted ...
GV Times
Contrasting of PDL BioPharma Inc. (PDLI) and Vertex ...
PDL BioPharma Inc. (NASDAQ:PDLI) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) compete with each other in the ...
Mayfield Recorder
PDL BioPharma (PDLI) Stock Price Down 5.6%
PDL BioPharma Inc (NASDAQ:PDLI) fell 5.6% on Thursday . The company traded as low as $3.03 and last traded at $3.03. 1,323,532 shares ...
Nasdaq Click - 16 hours ago
Nanometrics (NANO) Shareholder Truenorth Has Lifted Holding by ...
Nanometrics (NANO) Shareholder Truenorth Has Lifted Holding by $414,099 as Stock Declined; Rbf Capital Boosted Pdl Biopharma (PDLI) ...
The NBO News - 9 hours ago
PDL BioPharma, Inc. (PDLI): Why Is It Down -2.96 Percent Today
The biggest losers of the session on the Wall Street include PDL BioPharma, Inc. (NASDAQ:PDLI), which fell -0.09 points or -2.96% to trade at ...
Tech Know Bits - 3 days ago
Time to Turn Trash To Cash: KLA-Tencor Corporation (KLAC), PDL ...
For shares of PDL BioPharma, Inc. (NASDAQ: PDLI), there are currently ratings available from 1 different stock market analysts who have all ...
Mayfield Recorder
Evaluating the Risk element: PDL BioPharma, Inc. (PDLI), IQVIA ...
Through the past nine calendar days, PDL BioPharma, Inc. (NASDAQ: PDLI) stock was recorded as generating a Historic Volatility of 42.82%.
Nasdaq Click
PDL BioPharma, Inc. (PDLI): Best of Kind, But Long-Term Risks Linger
PDL BioPharma, Inc. (NASDAQ:PDLI) has had quite a year when it comes to price performance. This company's stock managed to rise to its ...


Back